Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE National Council on Patient Information and Education
Agenda-Setting Report Issued to Reduce Adverse Health and Economic Consequences
WASHINGTON, Oct. 15, 2013 /PRNewswire-USNewswire/ -- With mounting evidence that poor medicine adherence will increase dramatically with the projected rise in age-related chronic illnesses, the National Council on Patient Information and Education (NCPIE) – a non-profit coalition of diverse organizations working to improve communication on the safe and appropriate use of medicines – today released a ten-step Adherence Action Agenda that places the spotlight on the pervasive and costly problem of poor medicine adherence, particularly among those age 65 and older with multiple chronic conditions, who are at the greatest risk of medication errors, drug interactions and costly disease complications.
Issued as a nationwide call to action, the report – Accelerating Progress in Prescription Medicine Adherence: The Adherence Action Agenda – finds that poor medicine adherence among patients with chronic and comorbid conditions is resulting in unnecessary disease progression and disease complications and the increased use of expensive components of health care, such as emergency room visits, hospitalizations, avoidable hospital re-admissions and post-acute care. According to estimates cited in the report, caring for approximately 27% of Americans with multiple chronic conditions accounts for 66% of the nation's health expenditures and is a major source of Medicare spending. Of the $300 billion Medicare spent in 2010 on healthcare, beneficiaries with six or more chronic conditions – roughly 14% of the Medicare population – cost $32,658 or three times the national average. As a result, the price tag for treating patients with six or more concurrent diseases was over $140 billion, or almost half of Medicare's total spending.
"Although the challenge of poor medication adherence has been discussed and debated extensively, what is lacking is the clear recognition that prescription medicine use and the rising prevalence of chronic and comorbid conditions are inextricably linked and together, represent a major opportunity to address this health threat," said Ray Bullman, NCPIE's Executive Vice President. "This report is intended as a wakeup call that action is needed now to confront this combined threat, before the predicted continuing upsurge of chronic conditions overwhelms the healthcare system."
Coming six years after NCPIE issued the landmark report – Enhancing Prescription Medicine Adherence: A National Action Plan – which defined poor medicine adherence as the nation's "other drug problem," the new action plan was developed in collaboration with nearly two dozen professional societies, voluntary health organizations, consumer and aging organizations, government agencies and industry leaders and based on evidence that multiple medicine use is commonplace among older Americans, especially those with multiple chronic conditions: 42% of adults aged 65 and older took five or more prescription drugs in 2012 with the average number of drugs prescribed increasing from five at age 65 to seven at age 85. Further, there is a direct link between the number of medications taken by a patient and the risk of adverse drug reactions. Studies document a rise in the incidence of drug reactions from 6% in patients taking two medications a day to as high as 50% in patients taking five drugs a day.
Designed to provide up-to-date information about the state of prescription medicine adherence in the U.S. and the impact of multiple chronic conditions on appropriate medicine use, the report also identifies numerous behavioral, social, economic, medical, and policy-related factors that contribute to poor adherence in this patient population. This includes the complexity of the drug regimen, the need for patients to visit multiple pharmacies to fill different prescriptions, cost-control measures implemented by payers and health systems, poor communication between patients and clinicians, and the breakdown in provider communications during the transition to care from the hospital to the outpatient setting. All of these problems contribute to medication errors, poor health outcomes and higher health care costs and all must be addressed.
Ten New Priorities for Action
Intended to accelerate progress in appropriate medicine taking, the new Adherence Action Plan advocates for an increased focus on the overlooked challenge of multiple chronic conditions, where the need for patient adherence is most acute, and lays out these ten policy and programmatic solutions to improve medication adherence:
About the Report
To prepare this new report, in the fall of 2012, NCPIE commenced a new initiative called the Adherence Action Agenda or the "A3 Project," bringing together 22 professional societies and voluntary health organizations, government agencies and industry leaders to identify the major gaps in current adherence efforts and provide input into creation by NCPIE of a new Adherence Action Agenda for the nation. Members of the A3 Project are:
Support for development of the Adherence Action Agenda was provided by Merck, known as MSD outside the United States and Canada. NCPIE is solely responsible for the content, and maintains editorial control of all the materials and publications produced for the A3 Project.
Established in 1982, the National Council on Patient Information and Education is a diverse non-profit coalition that works to stimulate and improve the communication of information about the appropriate use of prescription and OTC medicines. NCPIE's members include consumer organizations: patient advocacy groups; voluntary health agencies; health professional associations, schools of pharmacy, health-related trade associations; prescription and over-the-counter pharmaceutical manufacturers; and local, state and federal government agencies. More information about NCPIE is available through its Web site: www.talkaboutrx.org.
©2012 PR Newswire. All Rights Reserved.